ERAS
GTPase ERas
Also known as: HRAS2, HRASP, RASE_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z444
- Gene
- ERAS
- Ensembl
- ENSG00000187682
- Chromosome
- X
- Canonical length
- 233 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a constitutively active member of the small GTPase Ras protein family. The encoded protein activates the phosphatidylinositol 3-kinase signal transduction pathway in undifferentiated stem cells, but is not expressed in differentiated cells. This gene may be involved in cancer and chemotherapy resistance. [provided by RefSeq, Dec 2012]
Canonical amino-acid sequenceUniProt
233 residues, UniProt reviewed canonical sequence.
>Q7Z444|ERAS
1 MELPTKPGTF DLGLATWSPS FQGETHRAQA RRRDVGRQLP EYKAVVVGAS GVGKSALTIQ
61 LNHQCFVEDH DPTIQDSYWK ELTLDSGDCI LNVLDTAGQA IHRALRDQCL AVCDGVLGVF
121 ALDDPSSLIQ LQQIWATWGP HPAQPLVLVG NKCDLVTTAG DAHAAAAALA HSWGAHFVET
181 SAKTRQGVEE AFSLLVHEIQ RVQEAMAKEP MARSCREKTR HQKATCHCGC SVALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERAS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 3.2 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 3.2 nTPM
- cerebellum: 2.5 nTPM
- amygdala: 1.1 nTPM
- basal ganglia: 1.1 nTPM
- cerebral cortex: 1 nTPM
- pituitary gland: 1 nTPM
Single-cell type
- paneth cells: 3.9 nCPM
- sertoli cells: 3.4 nCPM
- early primary spermatocytes: 2.8 nCPM
- differentiating spermatogonia: 2.2 nCPM
- other brain neurons: 2.2 nCPM
- astrocytes: 1.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 4.3 nTPM
- basal ganglia: 1.6 nTPM
- cerebral cortex: 1.6 nTPM
- midbrain: 1.5 nTPM
- cerebellum: 1.2 nTPM
- medulla oblongata: 1.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.45
- gnomAD pLI
- 0.22
- gnomAD missense Z
- 1.48
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ERAS in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERAS as an antibody target. Whether an autoantibody or antibody against ERAS could matter depends on whether native ERAS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERAS is annotated at the cell surface, where native ERAS is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ERAS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...